Chlormadinone acetate is effective for hot flush during androgen deprivation therapy

To investigate the clinical efficacy of low-dose chlormadinone acetate (CMA) in prostate cancer patients who suffer from hot flushes that is a major side effect of androgen deprivation therapy. Methods: Our study included 32 prostate cancer patients who had severe hot flush after undergoing hormone...

Full description

Bibliographic Details
Main Authors: Hidekazu Koike, Yasuyuki Morikawa, Hiroshi Matsui, Yasuhiro Shibata, Kazuto Ito, Kazuhiro Suzuki
Format: Article
Language:English
Published: Elsevier 2013-09-01
Series:Prostate International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2287888215300192

Similar Items